Alligator Bioscience AB (publ)
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ATORX.ST research report →
Companywww.alligatorbioscience.se
Alligator Bioscience AB (publ), a research-based biotechnology company, develops antibody-based drugs for cancer treatment in Sweden. It develops products using its technology platforms, including ALLIGATOR-GOLD and ALLIGATOR-FAB, a proprietary human antibody library that contains approximately 60 billion unique antibody fragments; FIND, a molecular evolution technology for optimization of antibodies and other proteins; and RUBY, a bispecific antibody format. The company develops Mitazalimab, an immunostimulatory CD40 antibody, which has completed Phase I clinical trial for the treatment of metastatic cancer; and ATOR-1017, an immunostimulatory antibody, which is in phase I clinical trial that binds to the receptor 4-1BB in tumor-specific T cells.
- CEO
- Søren Bregenholt
- IPO
- 2016
- Employees
- 33
- HQ
- Lund, SE
Price Chart
Valuation
- Market Cap
- $7.86M
- P/E
- -2.85
- P/S
- 13.04
- P/B
- 2.87
- EV/EBITDA
- -0.17
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -8152.57%
- Op Margin
- -13332.34%
- Net Margin
- -6892.87%
- ROE
- -3992.70%
- ROIC
- -109.14%
Growth & Income
- Revenue
- $514.00K · -99.11%
- Net Income
- $-51,350,000 · 78.05%
- EPS
- $-1.87 · 93.06%
- Op Income
- $-111,734,000
- FCF YoY
- 25.88%
Performance & Tape
- 52W High
- $7.21
- 52W Low
- $0.16
- 50D MA
- $0.21
- 200D MA
- $1.41
- Beta
- 1.24
- Avg Volume
- 17.31M
Get TickerSpark's AI analysis on ATORX.ST
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our ATORX.ST Coverage
We haven't published any research on ATORX.ST yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate ATORX.ST Report →